These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38315093)
1. Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity. Osman NA; Soltan MK; Rezq S; Flaherty J; Romero DG; Abdelkhalek AS Arch Pharm (Weinheim); 2024 May; 357(5):e2300615. PubMed ID: 38315093 [TBL] [Abstract][Full Text] [Related]
2. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. Lamie PF; Philoppes JN; Rárová L Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX. Omar YM; Abdu-Allah HHM; Abdel-Moty SG Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and molecular modeling of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazolinone derivatives as anti-inflammatory agents by inhibition of COX-2/iNOS production and down-regulation of NF-κB/MAPKs in LPS-induced RAW264.7 macrophage cells. Cai X; Cai J; Fang L; Xu S; Zhu H; Wu S; Chen Y; Fang S Eur J Med Chem; 2024 Jun; 272():116460. PubMed ID: 38704943 [TBL] [Abstract][Full Text] [Related]
6. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586 [TBL] [Abstract][Full Text] [Related]
8. Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation. Said MF; Marie SM; Mohamed NM; Mahrouse MA; Moussa BA Future Med Chem; 2024; 16(9):817-842. PubMed ID: 38634318 [TBL] [Abstract][Full Text] [Related]
10. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines. Abdelkhalek AS; Kothayer H; Rezq S; Orabi KY; Romero DG; El-Sabbagh OI Eur J Med Chem; 2023 Aug; 256():115443. PubMed ID: 37182334 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects. Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY. Abdelall EKA; Lamie PF; Ali WAM Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139 [TBL] [Abstract][Full Text] [Related]
15. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study. El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993 [TBL] [Abstract][Full Text] [Related]
16. Click chemistry synthesis, biological evaluation and docking study of some novel 2'-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Boshra AN; Abdu-Allah HHM; Mohammed AF; Hayallah AM Bioorg Chem; 2020 Jan; 95():103505. PubMed ID: 31901755 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells. Fang S; Huang X; Cai F; Qiu G; Lin F; Cai X J Steroid Biochem Mol Biol; 2024 Jun; 240():106478. PubMed ID: 38430971 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Gedawy EM; Kassab AE; El Kerdawy AM Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653 [TBL] [Abstract][Full Text] [Related]
20. Design and Synthesis of Novel 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives as Cyclooxygenase-2 Inhibitors with Anti-inflammatory and Antioxidant activity in LPS-stimulated RAW264.7 Macrophages. Hamoud MMS; Osman NA; Rezq S; A A Abd El-Wahab H; E A Hassan A; Abdel-Fattah HA; Romero DG; Ghanim AM Bioorg Chem; 2022 Jul; 124():105808. PubMed ID: 35447409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]